Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Millions		12 Months Ended
	Feb. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Segment assets		$ 39,658	$ 13,555
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		354	441	$ 557
Restructuring and Other Charges, net		(41)	(17)	(30)
Gain on Sale of Assets		1	(4)	(3)
Employee separation costs		4
Interest expense		(289)	(132)	(138)
Other income (expense), net		58	7	30
Revenue		11,656	5,084	5,140
Segment Adjusted Operating EBITDA		2,425	1,055	1,116
Shareholder Activism Related Costs		(7)	0	0
Business Divestiture Costs		(42)	0	0
Other Depreciation and Amortization		(1,156)	(325)	(323)
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Operational Improvement Initiatives		0	0	(2)
Restructuring and Other Charges, net		(41)	(17)	(30)
Gain on Sale of Assets		1	(4)	(3)
Employee separation costs		(29)	(3)	0
Legal Fees		0	(3)	(11)
Nourish
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net		(32)	(10)	(17)
Health & Biosciences
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net		(5)	0	(1)
Scent [Member]
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net		(3)	(7)	(12)
Pharma Solutions
Segment Reporting Information [Line Items]
Restructuring and Other Charges, net		(1)	0	0
Operating Segments [Member] | Nourish
Segment Reporting Information [Line Items]
Segment assets		17,449	8,534
Revenue		6,264	2,886	2,978
Segment Adjusted Operating EBITDA		1,172	599	658
Operating Segments [Member] | Health & Biosciences
Segment Reporting Information [Line Items]
Segment assets		14,774	1,375
Revenue		2,329	134	129
Segment Adjusted Operating EBITDA		625	40	33
Operating Segments [Member] | Scent [Member]
Segment Reporting Information [Line Items]
Segment assets		4,078	3,646
Revenue		2,254	2,064	2,033
Segment Adjusted Operating EBITDA		463	416	425
Operating Segments [Member] | Pharma Solutions
Segment Reporting Information [Line Items]
Segment assets		3,357	0
Revenue		809	0	0
Segment Adjusted Operating EBITDA		165	0	0
Nutrition & Biosciences, Inc [Member]
Segment Reporting Information [Line Items]
Acquisition Related Costs	$ (75)
Transaction costs		91	29		$ 21
Nutrition & Biosciences, Inc [Member] | Corporate and Other [Member]
Segment Reporting Information [Line Items]
Acquisition Related Costs		(91)	(29)	(21)
Integration Related Costs		(101)	(97)	0
Business Combination, Inventory Step-Up Costs		(368)	0	0
Frutarom Industries Ltd. [Member] | Corporate and Other [Member]
Segment Reporting Information [Line Items]
Acquisition Related Costs		(2)	(1)	(6)
Integration Related Costs		$ (4)	$ (10)	$ (55)